Study Stopped
The research has been transferred to another project leader.
Cognitive Load of Activity Participation Scale (CLAP): Development and Validation
1 other identifier
observational
40
1 country
1
Brief Summary
In this study, we develop and validate the " Cognitive Load of Activity Participation Scale" (CLAPs) to measure the frequency and the perceived levels of cognitive load of the elderly participating in various cognitive activities and as a reference for intervention and behavioral Indicators for lifestyle modifications to preventing and delaying dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2023
CompletedFirst Posted
Study publicly available on registry
March 1, 2023
CompletedStudy Start
First participant enrolled
March 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2023
CompletedApril 20, 2025
May 1, 2024
2 months
February 20, 2023
April 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Montreal Cognitive Assessment(MoCA)
The Montreal Cognitive Assessment (MoCA) is a sensitive tool for screening cognitive function in the early stages of cognitive degeneration.
10-15 mins
Geriatric Depression Scale-Short Form (GDS-S)
There are 15 questions for elderly in GDS-S used for screening depression state. It takes 5-7 minutes to complete.
5-7 minutes
Study Arms (4)
Normal
1. Participants living in the community. 2. No vision or hearing impairment. 3. No severe depression, or other neurological/mental disorders affecting cognitive function.
Subjective Cognitive Decline, SCD
1. The Montreal Cognitive Assessment (MoCA) score \>22 2. Use two questions to screen: "Compared with the previous situation, do you have memory problems?", "Has your family or relatives ever thought that you have memory problems compared with the previous situation?", the answer to both questions is yes. 3. Geriatric Depression Scale-Short Form (GDS-S) score \<8
Mild Cognitive Impairment, MCI
1. MCI diagnosed by neurologists or psychiatrists: the diagnosis of MCI is mainly in accordance with the revised consensus version of the diagnostic criteria (Winblad et al., 2004), that is, memory function score is 1.5 standard deviations below the value for age- and education-related norms on the third edition of Wechsler Memory Scale. 2. MoCA: with a range of scores of 17-23(\>17 , \<23) (Trzepacz et al., 2015) 3. Geriatric Depression Scale-Short Form (GDS-S) score \<8
Mild Dementia
1. has met the criteria of dementia 2. at the early stages
Eligibility Criteria
Normal: No vision or hearing impairment, and no severe depression, or other neurological/mental disorders affecting cognitive function SCD: Use two questions to screen: "Compared with the previous situation, do you have memory problems?", "Has your family or relatives ever thought that you have memory problems compared with the previous situation?", the answer to both questions is yes. MCI: meet the criteria of Mild Cognitive Impairment Mild Dementia: meet the criteria of dementia
You may qualify if:
- Years 1 and 2 of study:
- Participants living in the community, aged 65 or above.
- No vision or hearing impairment, able to communicate and read in Mandarin and Taiwanese.
- No severe depression, or other neurological/mental disorders affecting cognitive function.
- Third year of study:
- Subjective Cognitive Degeneration (SCD):
- Participants living in the community, aged 65 or above.
- No vision or hearing impairment, able to communicate and read in Mandarin and Taiwanese.
- The Montreal Cognitive Assessment (MoCA) score \>22
- Use two questions to screen: "Compared with the previous situation, do you have memory problems?", "Has your family or relatives ever thought that you have memory problems compared with the previous situation?", the answer to both questions is yes.
- Geriatric Depression Scale-Short Form (GDS-S) score \<8
- Mild Cognitive Impairment (MCI):
- Participants living in the community, aged 65 or above.
- No vision or hearing impairment, able to communicate and read in Mandarin and Taiwanese.
- MCI diagnosed by neurologists or psychiatrists: the diagnosis of MCI is mainly in accordance with the revised consensus version of the diagnostic criteria (Winblad et al., 2004), that is, memory function score is 1.5 standard deviations below the value for age- and education-related norms on the third edition of Wechsler Memory Scale.
- +6 more criteria
You may not qualify if:
- Years 1 and 2 of study:
- Have a history of diseases related to cognitive degeneration (for example: acute stroke, brain injury, unconsciousness, etc.), and those diagnosed with organic nerve damage, brain function disorders, and related neurology.
- People with serious mental illness or behavior problems.
- Third year of study:
- SCD:
- Cognitive changes caused by other mental, neurological diseases, or substance abuse, etc.
- Has met the diagnostic criteria of MCI or dementia
- Those who are unable to complete the cognitive test due to visual, auditory, physical or cognitive impairment
- MCI:
- Cognitive changes caused by other mental, neurological diseases, or substance abuse, etc.
- Has met the diagnostic criteria for dementia.
- Those who are unable to complete the cognitive test due to visual, auditory impairment
- Mild Dementia:
- Cognitive changes caused by other mental, neurological diseases, or substance abuse, etc.
- Those who cannot accept the cognitive test because they are visually or hearing impaired, or have serious physical disease and behavioral problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Medicine, National Taiwan University
Taipei, 10051, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Hui-Fen Mao, M.S.
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 14 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2023
First Posted
March 1, 2023
Study Start
March 16, 2023
Primary Completion
May 25, 2023
Study Completion
May 25, 2023
Last Updated
April 20, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
ethical issue